by Jordana Choucair | Dec 19, 2022 | Health IT, Opioid/Substance Use Disorders
Senators Roger Marshall and Jeanne Shaheen plan to introduce legislation that will require social media companies to report fentanyl activity to law enforcement. The legislation would add to House Republicans’ strategy to increase oversight of tech...
by Jordana Choucair | Dec 14, 2022 | Opioid/Substance Use Disorders
The Substance Abuse and Mental Health Services Administration (SAMHSA) released a proposed rule that would make permanent the COVID-19 public health emergency policies that expanded access to opioid addiction medications. The rule would specifically make it easier for...
by Jordana Choucair | Dec 13, 2022 | Opioid/Substance Use Disorders
CVS and Walgreens have agreed to pay a combined $10.7 billion to settle allegations they failed to adequately oversee opioid painkiller prescriptions. CVS will pay $4.9 billion to states and political subdivisions and approximately $130 million to tribes. Walgreens...
by Jordana Choucair | Dec 9, 2022 | Opioid/Substance Use Disorders
The White House launched a new national dashboard to track non-fatal opioid overdoses and provide first responders, clinicians, and policymakers with real-time, actionable information to improve the country’s response and save lives. The Nonfatal Opioid Overdose...
by Jordana Choucair | Dec 2, 2022 | Opioid/Substance Use Disorders
A bipartisan bill to increase access to treatment for opioid addiction has a good chance of being rolled into a year-end package during the lame-duck session. The bill would remove a requirement that health care providers get a special waiver from the Drug Enforcement...
by Jordana Choucair | Dec 1, 2022 | Opioid/Substance Use Disorders
A Kaiser Health News article discusses ways to expand access buprenorphine to help treat addiction and prevent relapse. Industry experts offered several solutions, including: 1) emergency room doctors could prescribe a few days’ worth of the medication for a patient...
Recent Comments